Requesting the President to transmit certain information to the House of Representatives relating to a waiver of intellectual property commitments under the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights.

Bill 117 H.Res. 1285, also known as the Requesting the President to transmit certain information to the House of Representatives relating to a waiver of intellectual property commitments under the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights, is a resolution introduced in the US Congress.

The purpose of this resolution is to request the President of the United States to provide certain information to the House of Representatives regarding a potential waiver of intellectual property commitments under the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement).

The TRIPS Agreement is an international agreement that sets out minimum standards for the protection of intellectual property rights, including patents, trademarks, and copyrights. The resolution seeks to gather information on the potential impact of waiving these commitments on US businesses and industries, as well as on global access to essential medicines and technologies. The resolution highlights the ongoing debate over whether intellectual property rights should be waived in order to increase access to vaccines, treatments, and other medical technologies needed to combat the COVID-19 pandemic. Proponents argue that waiving these rights would allow for the rapid production and distribution of these essential products, particularly in developing countries where access is limited. Opponents, however, argue that waiving intellectual property rights could undermine incentives for innovation and investment in research and development, ultimately harming US businesses and industries. The resolution aims to gather information on both sides of the debate in order to inform future policy decisions on this issue. Overall, Bill 117 H.Res. 1285 seeks to promote transparency and informed decision-making regarding the potential waiver of intellectual property commitments under the TRIPS Agreement, with the ultimate goal of balancing the need for global access to essential medicines and technologies with the protection of intellectual property rights.